Jane Street Group, LLC Cardiff Oncology, Inc. Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 16, 2021
BUY
$5.01 - $7.58 $107,214 - $162,212
21,400 Added 152.86%
35,400 $236,000
Q2 2021

Aug 16, 2021
SELL
$6.65 - $10.04 $21,945 - $33,132
-3,300 Reduced 19.08%
14,000 $93,000
Q4 2020

Feb 17, 2021
SELL
$12.02 - $24.71 $343,772 - $706,706
-28,600 Reduced 62.31%
17,300 $311,000
Q3 2020

Nov 17, 2020
BUY
$4.25 - $14.19 $195,075 - $651,321
45,900 New
45,900 $651,000

Others Institutions Holding CRDF

# of Institutions
90
Shares Held
12.3M
Call Options Held
813K
Put Options Held
91.1K
View Full List

About Cardiff Oncology, Inc.

CRDF Quotes by TradingView
  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $185M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email